Revolution Medicines stockholders elect four Class II directors, ratify PwC, approve say-on-pay at 2025 annual meeting

Revolution Medicines, Inc.

Directors elected: Frank Clyburn, Sandra Horning, Sushil Patel, Thilo Schroeder; each received >119M votes for.
Ratified PricewaterhouseCoopers as independent auditor for FY2025 with 157.9M votes for, 215K against.
Advisory say-on-pay approved with 145.3M votes for, 2.6M against, 10.2M broker non-votes.
Record date April 28, 2025; 186.3M shares outstanding and entitled to vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.